Latest market price
6.38
-0.25-3.77%
CAPRQT40Capricor Therapeutics, Inc.·NASDAQ
6.38-3.77%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 24, 20268-KCurrent report
Aug 19, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 202610-QQuarterly report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 13, 20268-KCurrent report
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 03, 2026SC 13GBeneficial ownership statement (passive)
Jul 30, 20268-KCurrent report
Jul 29, 20268-KCurrent report
Jul 14, 20268-KCurrent report
Jun 29, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 26, 20268-KCurrent report
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 08, 20268-KCurrent report
May 28, 20264Statement of changes in beneficial ownership
May 28, 20263Initial statement of beneficial ownership
May 19, 20264Statement of changes in beneficial ownership
May 14, 20264Statement of changes in beneficial ownership
May 13, 202610-QQuarterly report
May 12, 20268-KCurrent report
May 07, 20268-KCurrent report